Posted by on Oct 17, 2020 in Coronary artery disease | 0 comments

In a nutshell This study investigated if certain types of anti-hypertensive drugs (AHTs) reduce risks after revascularization procedures for a heart attack. They found that beta-blockers (BBs) and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs) reduce cardiovascular events (CVEs) after revascularization. Some...

Read More